Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DWRX1010 is an oral colonoscopy bowel preparation drug developed by Daewoong Pharmaceutical. It is formulated as minitablets to maximize patient compliance and convenience, requiring low water intake compared to traditional preparations. The product contains simethicone, which helps remove foam in the colon, thereby enabling a smoother and more effective colonoscopy procedure. DWRX1010 aims to address common issues with existing bowel cleansers such as unpleasant taste, smell, and high volume requirements by offering improved tolerability and efficacy in bowel cleansing. As of mid-2025, it has completed non-clinical trials and patent applications in Korea and the US; a local Phase 3 clinical trial is ongoing with completion expected soon[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DWRX1010.